Guideline-changing trial results released earlier in 2019 suggest that SGLT2 inhibitors could be a viable treatment solution for patients with diabetes and evidence of kidney damage.
Power of one: what is holding polypills back?Subscription
Single pills with fixed-dose combinations of several medicines are not commonplace for the treatment of cardiovascular disease. As the first randomised controlled trial to show a polypill can cut the risk of heart attacks is published, we look at why, nearly two decades after it was first proposed, development and uptake is limited.
Case-based learning: sore throatSubscription
Most sore throats are caused by viral infections and get better within a week through self-care. However, it is important to recognise when a sore throat is a symptom of a more serious illness.
Should pharmacies be able to supply high-dose statins without a prescription?